United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 373.785 USD 3.43% Market Closed
Market Cap: 16.6B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

United Therapeutics Corp
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

United Therapeutics Corp
Other Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
United Therapeutics Corp
NASDAQ:UTHR
Other Current Assets
$220.8m
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
18%
Abbvie Inc
NYSE:ABBV
Other Current Assets
$4.7B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
6%
Gilead Sciences Inc
NASDAQ:GILD
Other Current Assets
$2.9B
CAGR 3-Years
25%
CAGR 5-Years
5%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Other Current Assets
$3B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Assets
$575.4m
CAGR 3-Years
5%
CAGR 5-Years
31%
CAGR 10-Years
33%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Assets
$681.9m
CAGR 3-Years
15%
CAGR 5-Years
27%
CAGR 10-Years
21%

See Also

What is United Therapeutics Corp's Other Current Assets?
Other Current Assets
220.8m USD

Based on the financial report for Jun 30, 2024, United Therapeutics Corp's Other Current Assets amounts to 220.8m USD.

What is United Therapeutics Corp's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
18%

Over the last year, the Other Current Assets growth was 39%. The average annual Other Current Assets growth rates for United Therapeutics Corp have been 36% over the past three years , 24% over the past five years , and 18% over the past ten years .

Back to Top